TG: A Mediator of the Relationship of Serum Uric Acid to Creatinine Ratio and Nonalcoholic Fatty Liver Disease in Non-Obese Patients with Type 2 Diabetes
Qing Wang,Ke Liu,Tian Zhang,Ting Wang,Huan Li,Chang Wang,Jinhu Chen,Luping Ren
DOI: https://doi.org/10.2147/dmso.s451852
2024-02-26
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Qing Wang, 1 Ke Liu, 1 Tian Zhang, 1 Ting Wang, 2 Huan Li, 1 Chang Wang, 1 Jinhu Chen, 1 Luping Ren 1 1 Department of Endocrinology, Hebei General Hospital, Shijiazhuang, Hebei, People's Republic of China; 2 Department of Clinical laboratory, Nanjing Medical College, Nanjing, Jiangsu, People's Republic of China Correspondence: Luping Ren, Email Background: The study estimated the association between NAFLD and SUA/Cr in Chinese non-obese patients with type 2 diabetes mellitus (T2DM) and also investigated mediating effect of TG. Methods: All patients were divided into NAFLD group (n = 420) and non-NAFLD group (n = 347). The differences of biochemical indicators between the two groups were compared. The link between SUA/Cr and other parameters was checked through Spearman correlation analysis. Differences in the incidence rate of NAFLD between SUA/Cr and TG 3 tertile subgroups were tested by chi-squared. To explore the independent influence of SUA/Cr and TG on NAFLD, logistic regression was performed. The predictive value of SUA/Cr and SUA/Cr combined with BMI for NAFLD was analyzed using ROC curves. In addition, to confirm whether TG has a mediating effect on the link of SUA/Cr and NAFLD, we conducted a mediating analysis. Results: NAFLD group had higher SUA/Cr values than individuals without NAFLD (P < 0.01). SUA/Cr was linked with TC and TG (r = 0.081, 0.215 respectively). NAFLD prevalence increased progressively from quartile 1 to quartile 3 of SUA/Cr (44% vs 57% vs 62%). Prevalence of NAFLD increased from quartile 1 to quartile 3 of TG (35.8% vs 58.7% vs 69.9%). Analysis of the logistic regression revealed that SUA/Cr and TG were statistically linked with NAFLD. The ROC curve pointed out that the area under the curve (AUC), sensitivity and specificity of SUA/Cr were 0.59, 0.629 and 0.522, respectively. The AUC, sensitivity and specificity for SUA/Cr combined with BMI were 0.719, 0.644 and 0.677, separately. The mediation analysis showed a statistically direct effect of SUA/Cr on NAFLD (β=0.148, 95% CI: 0.0393, 0.2585). The function of SUA/Cr on NAFLD partially mediated by TG (β=0.1571, 95% CI: 0.0704, 0.2869). Conclusion: SUA/Cr was significantly associated with NAFLD in non-obese T2DM patients, and TG partially mediated this association. SUA/Cr can be applied to predict for NAFLD. Keywords: nonalcoholic fatty liver disease, type 2 diabetes mellitus, serum uric acid to creatinine ratio Non-alcoholic fatty liver disease (NAFLD) is a series of diseases in which steatosis of at least 5% of hepatocytes in the liver has been confirmed by or histologic examination or imaging, while steatohepatic liver injury due to known damaging factors, such as excessive alcohol consumption, viral infections, or drugs, is excluded. 1 NAFLD can progress from the early stages of liver steatosis to liver failure, liver cirrhosis and even hepatoma. In addition to hepatic manifestations, NAFLD raises a range of extrahepatic diseases. NAFLD has been reported to be linked to adverse cardiovascular events, 2 extrahepatic tumors, 3 chronic kidney disease, 4 etc. NAFLD and T2DM, as common metabolic disorders, tend to go hand in hand. NAFLD seems to be more common in diabetes patients. A meta-analysis suggests that the NAFLD incidence rate is up to 65% among T2DM patients worldwide. 5 With diabetes and obesity prevalence on the upswing, the incidence of NAFLD is anticipated to continue to increase. The bidirectional link between NAFLD and T2DM was commendably confirmed in prior studies. NAFLD is an independent risk factor in T2DM, 6 while the prevalence of T2DM progressing to NAFLD is significantly higher compared to the general population, with approximately 50% or more T2DM combined with NAFLD. 5 Worryingly, patients with NAFLD combined with T2DM have a significantly higher incidence of diabetic microvascular diseases such as diabetic peripheral neuropathy or diabetic nephropathy. 7 Given the high incidence rate of NAFLD and the multiple adverse outcomes associated with it, the early discovery of NAFLD in T2DM patients is of particular importance. In prior researches, serum uric acid (SUA) showed a strong connection with metabolic syndrome, 8,9 and NAFLD has also been revealed to be linked with SUA as hepatic phenotype of metabolic syndrome. 10 Creatinine (Cr) is an index of renal function. Recent cross-sectional research revealed that Cr was associated with NAFLD even if Cr was in the regular reference interval. 11 Recently, the combination of these two metabolic indicators SUA/Cr has triggered an increasing interest, and since SUA is inf -Abstract Truncated-
endocrinology & metabolism